Search hospitals > California > Palo Alto

Stanford Cancer Institute Palo Alto

Claim this profile
Palo Alto, California 94304
Global Leader in Parotid Gland Cancer
Global Leader in Lymphoma
Conducts research for Cancer
Conducts research for Adult T-Cell Leukemia/Lymphoma
Conducts research for Breast Cancer
556 reported clinical trials
67 medical researchers
Photo of Stanford Cancer Institute Palo Alto in Palo AltoPhoto of Stanford Cancer Institute Palo Alto in Palo AltoPhoto of Stanford Cancer Institute Palo Alto in Palo Alto

Summary

Stanford Cancer Institute Palo Alto is a medical facility located in Palo Alto, California. This center is recognized for care of Parotid Gland Cancer, Lymphoma, Cancer, Adult T-Cell Leukemia/Lymphoma, Breast Cancer and other specialties. Stanford Cancer Institute Palo Alto is involved with conducting 556 clinical trials across 567 conditions. There are 67 research doctors associated with this hospital, such as Andrei Iagaru, MD, Robert Lowsky, MD, Christopher Chen, and Lori Muffly, MD.

Area of expertise

1Parotid Gland Cancer
Global Leader
Stanford Cancer Institute Palo Alto has run 107 trials for Parotid Gland Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage II
2Lymphoma
Global Leader
Stanford Cancer Institute Palo Alto has run 94 trials for Lymphoma. Some of their research focus areas include:
Stage IV
Stage III
Stage II

Top PIs

Clinical Trials running at Stanford Cancer Institute Palo Alto

Breast Cancer
Cancer
Lung Cancer
Parotid Gland Cancer
Skin Cancer
Ovarian Cancer
Non-Small Cell Lung Cancer
Breast cancer
Squamous Cell Carcinoma
Lymphoma
Image of trial facility.

Radiation Therapy

for Brain Metastasis

This phase III trial compares the effectiveness of fractionated stereotactic radiosurgery (FSRS) to usual care stereotactic radiosurgery (SRS) in treating patients with cancer that has spread from where it first started to the brain. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. FSRS delivers a high dose of radiation to the tumor over 3 treatments. SRS is a type of external radiation therapy that uses special equipment to position the patient and precisely give a single large dose of radiation to a tumor. FSRS may be more effective compared to SRS in treating patients with cancer that has spread to the brain.
Recruiting2 awards Phase 312 criteria
Image of trial facility.

Radiation and HER2-Targeted Therapy

for Breast Cancer

This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Image of trial facility.

Pembrolizumab

for Triple-Negative Breast Cancer

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Stanford Cancer Institute Palo Alto?
Where is Stanford Cancer Institute Palo Alto located?
Who should I call to ask about financial aid or insurance network?
What insurance does Stanford Cancer Institute Palo Alto accept?
What awards or recognition has Stanford Cancer Institute Palo Alto received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security